4Banada PP,Sivasubramani SK,Blakemore R,et al.Containment of bioaerosolinfection risk by the Xpert MTB/RIF Assay and itsapplicability to point-of-care settings[J].J Clin Microbiol,2010,48(10):3551-3557.
5Boehme CC,Nabeta P,Hillemann D,et al.Rapid molecular detection of tuberculosis and rifampin resistance[J].N Engl J Med,2010,363(11):1005-1015.
6Blakemore R,Story E,Helb D,et al.Evaluation of theanalytical performance of the Xpert MTB/RIF Assay[J].JClin Microbiol,2010,48(7):2495-2501.
7Helb D,Jones M,Story E,et al.Rapid detection of Mycobacterium tuberculosis and rifampinresistance by use of on-demand,near-patient technology[J].J Clin Microbiol,2010,48(1):229-237.
8Boehme CC,Nicol MP,Nabeta P,et al.Feasibility,diagnostic accuracy,and effectiveness of decentraliaed ues of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance;a multicenter implementation study[J].Lance,2011,377(9776):1495-1505.
9Rosso F,Michelon CT,Sperhacke RD,et a1.Evaluation 0f real-time Pc R of pa Ijent pleural efhlsion for diaosis 0f tuberculosis[J].BMc research notes,2011(4):279.
10Pang Y,Zhou Y,Zhao B,et a1.Spoligotyping and drug resistanceanalysis of Myeobacterium tuberculosis strains from national survey in China[J].I.PIxl S One,2012(7):e32976.
